186 related articles for article (PubMed ID: 16160941)
1. Optimizing candidate selection--a vision in business limited conference. 1-2 December 1998, Basel, Switzerland.
Audus KL
IDrugs; 1999 Feb; 2(2):91-3. PubMed ID: 16160941
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. IBC's Drug Discovery Technology - Europe 2001. 23-26 April 2001, Stuttgart, Germany.
Kubinyi H
IDrugs; 2001 Jul; 4(7):776-82. PubMed ID: 15995933
[TBL] [Abstract][Full Text] [Related]
4. Strategies and techniques for identification of novel bioactive compounds--CHI's second annual conference. 7-9 October 1998, Zurich, Switzerland.
Kubinyi H
IDrugs; 1998 Dec; 1(8):883-6. PubMed ID: 16196479
[TBL] [Abstract][Full Text] [Related]
5. Applications of emerging technologies in toxicology and safety assessment.
Reynolds VL
Int J Toxicol; 2005; 24(3):135-7. PubMed ID: 16040564
[TBL] [Abstract][Full Text] [Related]
6. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
7. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
8. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
9. INFOTECHpharma '99--the information revolution in the pharmaceutical industry. 28-29 January 1999, London, UK.
Kibble A; Ekuban L; Muhsin M
IDrugs; 1999 Apr; 2(4):300-3. PubMed ID: 16158348
[TBL] [Abstract][Full Text] [Related]
10. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
11. Beginning to manage drug discovery and development knowledge.
Sumner-Smith M
Curr Opin Drug Discov Devel; 2001 May; 4(3):319-24. PubMed ID: 11560065
[TBL] [Abstract][Full Text] [Related]
12. Rational approaches to natural-product-based drug design.
Haustedt LO; Mang C; Siems K; Schiewe H
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):445-62. PubMed ID: 16889228
[TBL] [Abstract][Full Text] [Related]
13. Integrated expressional analysis: application to the drug discovery process.
Ilyin SE; Horowitz D; Belkowski SM; Xin H; Eckardt AJ; Darrow AL; Chen C; Maley D; D'Andrea M; Plata-Salamán CR; Derian CK
Methods; 2005 Nov; 37(3):280-8. PubMed ID: 16308157
[TBL] [Abstract][Full Text] [Related]
14. Compound scale-up at the discovery-development interface.
Nikitenko AA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
[TBL] [Abstract][Full Text] [Related]
15. Metabolites in safety testing: metabolite identification strategies in discovery and development.
Nedderman AN
Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286
[TBL] [Abstract][Full Text] [Related]
16. Millennium conference 2005 on medical simulation: a summary report.
Huang GC; Gordon JA; Schwartzstein RM
Simul Healthc; 2007; 2(2):88-95. PubMed ID: 19088612
[TBL] [Abstract][Full Text] [Related]
17. Advances in knowledge management for pharmaceutical research and development.
Torr-Brown S
Curr Opin Drug Discov Devel; 2005 May; 8(3):316-22. PubMed ID: 15892246
[TBL] [Abstract][Full Text] [Related]
18. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
19. Predictive toxicology in drug discovery--second international conference. New technologies for predicting toxic responses at an early stage. 10-11 November 1999, New Orleans, LA, USA.
Tugwood J
IDrugs; 2000 Feb; 3(2):179-81. PubMed ID: 16107935
[TBL] [Abstract][Full Text] [Related]
20. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
